| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 3,312,000 | 3,133,000 | 3,508,000 | 3,229,000 | | Cost of Revenue | 1,219,000 | 2,742,000 | 3,911,000 | 341,000 | | | Gross Profit | 2,093,000 | 391,000 | (403,000) | 2,888,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,004,000 | (503,000) | (1,492,000) | 1,820,000 | | Non Recurring | (6,000) | (13,000) | 80,000 | (33,000) | | Others | 414,000 | 407,000 | 432,000 | 418,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 681,000 | 500,000 | 577,000 | 683,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 22,000 | 45,000 | 29,000 | 75,000 | | Earnings Before Interest And Taxes | 709,000 | 546,000 | 524,000 | 699,000 | | Interest Expense | 184,000 | 189,000 | 176,000 | 194,000 | | Income Before Tax | 525,000 | 357,000 | 348,000 | 505,000 | | Income Tax Expense | 179,000 | 95,000 | 132,000 | 167,000 | | Minority Interest |
-
| 1,000 | 2,000 | 2,000 | | | | Net Income From Continuing Ops | 346,000 | 262,000 | 216,000 | 338,000 | | | Non-recurring Events | | Discontinued Operations | 3,000 | 2,000 | (1,000) | 13,000 | | Extraordinary Items |
-
| 67,000 |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 349,000 | 331,000 | 215,000 | 351,000 | | Preferred Stock And Other Adjustments | (5,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $344,000 | $331,000 | $215,000 | $351,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
